Last edition
News about "Mediar Therapeutics"
Mediar Therapeutics, Ono Pharma Enter Collaboration to Develop Novel Fibrosis Therapies
Mediar Therapeutics and Ono Pharmaceutical have entered a collaboration and option agreement to discover novel therapies targeting fibro-inflammatory diseases, while Mediar advances its pipeline of fibrosis-focused antibody programmes.
Mediar Therapeutics | 10/08/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members